Anne Ma Dyrhol-Riise
Position:
Phone: +47 22 11 73 97
Email:
 

Author network for Anne Ma Dyrhol-Riise by COREMINE medical


Publications 2017

Brekke K, Sommerfelt M, Ökvist M, Dyrhol-Riise AM, Kvale D (2017)
The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
BMC Infect Dis, 17 (1), 228
PubMed 28340570

Feruglio SL, Kvale D, Dyrhol-Riise AM (2017)
T Cell Responses and Regulation and the Impact of In Vitro IL-10 and TGF-β Modulation During Treatment of Active Tuberculosis
Scand J Immunol, 85 (2), 138-146
PubMed 27862137

Prebensen C, Trøseid M, Ueland T, Dahm A, Sandset PM, Aaberge I, Waalen K, Dyrhol-Riise AM, Taskén K, Kvale D (2017)
Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
PLoS One, 12 (5), e0176527
PubMed 28464042

Publications 2016

Jensenius M, Winje BA, Blomberg B, Mengshoel AT, Lippe Bv, Hannula R, Bruun JN, Knudsen PK, Rønning JO, Heldal E, Dyrhol-Riise AM (2016)
Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014
Int J Tuberc Lung Dis, 20 (6), 786-92
PubMed 27155182

Prebensen C, Lind A, Dyrhol-Riise AM, Kvale D (2016)
Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy
PLoS One, 11 (4), e0153849
PubMed 27128502

Stiksrud B, Lorvik KB, Kvale D, Mollnes TE, Ueland PM, Trøseid M, Taskén K, Dyrhol-Riise AM (2016)
Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts
J Acquir Immune Defic Syndr, 73 (2), 138-48
PubMed 27632144

Tonby K, Wergeland I, Lieske NV, Kvale D, Tasken K, Dyrhol-Riise AM (2016)
The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
BMC Infect Dis, 16 (1), 599
PubMed 27776487

Wergeland I, Assmus J, Dyrhol-Riise AM (2016)
Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls
PLoS One, 11 (9), e0163848
PubMed 27685462

Publications 2015

Feruglio SL, Tonby K, Kvale D, Dyrhol-Riise AM (2015)
Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
Clin Exp Immunol, 179 (3), 454-65
PubMed 25313008

Lieske NV, Tonby K, Kvale D, Dyrhol-Riise AM, Tasken K (2015)
Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
PLoS One, 10 (11), e0141903
PubMed 26544592

Prebensen C, Ueland T, Michelsen AE, Lind A, Pettersen FO, Mollnes TE, Aukrust P, Dyrhol-Riise AM, Kvale D (2015)
High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection
J Acquir Immune Defic Syndr, 69 (4), 395-402
PubMed 26115437

Stiksrud B, Nowak P, Nwosu FC, Kvale D, Thalme A, Sonnerborg A, Ueland PM, Holm K, Birkeland SE, Dahm AE, Sandset PM, Rudi K, Hov JR, Dyrhol-Riise AM, Trøseid M (2015)
Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
J Acquir Immune Defic Syndr, 70 (4), 329-37
PubMed 26258571

Tonby K, Ruhwald M, Kvale D, Dyrhol-Riise AM (2015)
IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
Sci Rep, 5, 9223
PubMed 25783975

Wergeland I, Pullar N, Assmus J, Ueland T, Tonby K, Feruglio S, Kvale D, Damås JK, Aukrust P, Mollnes TE, Dyrhol-Riise AM (2015)
IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy
J Infect, 70 (4), 381-91
PubMed 25597826

Publications 2014

Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Mannsåker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F (2014)
Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient
Genome Biol, 15 (11), 490
PubMed 25418686

Pettersen PS, Brox IK, Naman E, Bruun JN, Dyrhol-Riise AM, Trøseid M, Johannessen A (2014)
Antiretroviral treatment failure predicts mortality in rural Tanzania
Int J STD AIDS, 26 (9), 633-9
PubMed 25122578

Pullar ND, Steinum H, Bruun JN, Dyrhol-Riise AM (2014)
HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study
BMC Infect Dis, 14, 667
PubMed 25515915

Pullar ND, Steinum H, Tonby K, Heggelund L, Leiva RA, Ofstad R, Bruun JN, Dyrhol-Riise AM (2014)
Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway
Int J Tuberc Lung Dis, 18 (2), 180-7
PubMed 24429310

Publications 2013

Feruglio SL, Trøseid M, Damås JK, Kvale D, Dyrhol-Riise AM (2013)
Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses
PLoS One, 8 (7), e69896
PubMed 23875007

Gran G, Aßmus J, Dyrhol-Riise AM (2013)
Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results
BMC Public Health, 13, 353
PubMed 23590619

Lind A, Brekke K, Sommerfelt M, Holmberg JO, Aass HC, Baksaas I, Sørensen B, Dyrhol-Riise AM, Kvale D (2013)
Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms
Vaccine, 31 (41), 4611-8
PubMed 23906886

Publications 2011

Hesstvedt L, Wilhelmsen M, Mengshoel AT, Dyrhol-Riise AM (2011)
Two Norwegian patients with melioidosis presenting with bacteraemia and splenic and prostatic abscesses
J Travel Med, 18 (6), 418-21
PubMed 22017720

Wergeland I, Assmus J, Dyrhol-Riise AM (2011)
T regulatory cells and immune activation in Mycobacterium tuberculosis infection and the effect of preventive therapy
Scand J Immunol, 73 (3), 234-42
PubMed 21204895

Publications 2010

Dyrhol-Riise AM, Gran G, Wentzel-Larsen T, Blomberg B, Haanshuus CG, Mørkve O (2010)
Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country
BMC Infect Dis, 10, 57
PubMed 20210999

Publications 2009

Storla DG, Kristiansen I, Oftung F, Korsvold GE, Gaupset M, Gran G, Øverby AK, Dyrhol-Riise AM, Bjune GA (2009)
Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposure
BMC Infect Dis, 9, 60
PubMed 19432995

Publications 2008

Baba K, Dyrhol-Riise AM, Sviland L, Langeland N, Hoosen AA, Wiker HG, Mustafa T (2008)
Rapid and specific diagnosis of tuberculous pleuritis with immunohistochemistry by detecting Mycobacterium tuberculosis complex specific antigen MPT64 in patients from a HIV endemic area
Appl Immunohistochem Mol Morphol, 16 (6), 554-61
PubMed 18698260

Baba K, Hoosen AA, Langeland N, Dyrhol-Riise AM (2008)
Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts
PLoS One, 3 (7), e2788
PubMed 18665218

Baba K, Pathak S, Sviland L, Langeland N, Hoosen AA, Asjo B, Dyrhol-Riise AM, Mustafa T (2008)
Real-time quantitative PCR in the diagnosis of tuberculosis in formalin-fixed paraffin-embedded pleural tissue in patients from a high HIV endemic area
Diagn Mol Pathol, 17 (2), 112-7
PubMed 18382372

Baba K, Sørnes S, Hoosen AA, Lekabe JM, Mpe MJ, Langeland N, Dyrhol-Riise AM (2008)
Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-gamma assay
BMC Infect Dis, 8, 35
PubMed 18366633

Winje BA, Oftung F, Korsvold GE, Mannsåker T, Ly IN, Harstad I, Dyrhol-Riise AM, Heldal E (2008)
School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay
BMC Infect Dis, 8, 140
PubMed 18928541

Publications 2006

Voltersvik P, Bostad L, Dyrhol-Riise AM, Eide GE, Røsok BI, Olofsson J, Asjö B (2006)
Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy
J Acquir Immune Defic Syndr, 41 (3), 277-84
PubMed 16540928

Wiker HG, Mustafa T, Målen H, Riise AM (2006)
Vaccine approaches to prevent tuberculosis
Scand J Immunol, 64 (3), 243-50
PubMed 16918693

Publications 2003

Voltersvik P, Albrektsen G, Ulvestad E, Dyrhol-Riise AM, Sørensen B, Asjö B (2003)
Changes in immunoglobulin isotypes and immunoglobulin G (IgG) subclasses during highly active antiretroviral therapy: anti-p24 IgG1 closely parallels the biphasic decline in plasma viremia
J Acquir Immune Defic Syndr, 34 (4), 358-67
PubMed 14615653

Publications 2001

Dyrhol-Riise AM, Ohlsson M, Skarstein K, Nygaard SJ, Olofsson J, Jonsson R, Asjö B (2001)
T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy
Clin Immunol, 101 (2), 180-91
PubMed 11683577

Dyrhol-Riise AM, Stent G, Røsok BI, Voltersvik P, Olofsson J, Asjö B (2001)
The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy
Clin Immunol, 101 (2), 169-79
PubMed 11683576

Dyrhol-Riise AM, Voltersvik P, Berg OG, Olofsson J, Kleivbo S, Asjö B (2001)
Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization
AIDS Res Hum Retroviruses, 17 (7), 577-86
PubMed 11375053

Publications 2000

Dyrhol-Riise AM, Brantsaeter AB, Dunlop O, Baklien K, Skar AG, Asjö B, Bruun JN, Røsok BI (2000)
Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals
Scand J Immunol, 51 (2), 195-201
PubMed 10652164

Dyrhol-Riise AM, Voltersvik P, Røsok BI, Olofsson J, Asjö B (2000)
Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection
AIDS Res Hum Retroviruses, 16 (3), 191-201
PubMed 10710207

Voltersvik P, Dyrhol-Riise AM, Bostad L, Røsok BI, Olofsson J, Asjö B (2000)
Changes in tonsillar tissue in early HIV-1 infection and during 3 years of antiretroviral therapy
APMIS, 108 (7-8), 539-50
PubMed 11167551

Publications 1999

Dyrhol-Riise AM, Voltersvik P, Olofsson J, Asjö B (1999)
Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection
AIDS, 13 (17), 2365-76
PubMed 10597778